MicroRNA-550a Acts as a Pro-Metastatic Gene and Directly Targets Cytoplasmic Polyadenylation Element-Binding Protein 4 in Hepatocellular Carcinoma

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Tian, Qi ^a   Liang, Linhui ^a   Ding, Jie ^a   Zha, Ruopeng ^a   Shi, Haibing ^a   Wang, Qifeng ^a   Huang, Shenglin ^a   Guo, Weijie ^a   Ge, Chao ^a   Chen, Taoyang ^b   Li, Jinjun ^a   He, Xianghuo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Qi Dong Liver Cancer Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN 4; MICRORNA; MICRORNA 550A; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; CPEB4 GENE; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GENE ACTIVITY; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER METASTASIS; LOSS OF FUNCTION MUTATION; ONCOGENE; OVERALL SURVIVAL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TARGETING;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CYTOPLASM; DOWN-REGULATION; HEK293 CELLS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYADENYLATION; RNA-BINDING PROTEINS; UP-REGULATION;

EID: 84868703865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048958     Document Type: Article

References (32)

1. Bartel DP, (2004) Genomics, Biogenesis, Mechanism, and Function. Cell 116: 281-297.
2. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
3. Croce CM, Calin GA, (2005) miRNAs, cancer, and stem cell division. Cell 122: 6-7.
4. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
5. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
6. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004.
7. He L, Hannon GJ, (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
8. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230.
9. Zhang B, Pan X, Cobb GP, Anderson TA, (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12.
10. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127: 2893-2917.
12. Ding J, Huang S, Wu S, Zhao Y, Liang L, et al. (2010) Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nature Cell Biology 12: 390-399.
13. Gutierrez NC, Sarasquete ME, Misiewicz-Krzeminska I, Delgado M, De Las Rivas J, et al. (2010) Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling. Leukemia 24: 629-637.
14. Lu Y, Ryan SL, Elliott DJ, Bignell GR, Futreal PA, et al. (2009) Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. PLoS ONE 4: e6159.
15. Koizumi Y, Tanaka S, Mou R, Koganei H, Kokawa A, et al. (1997) Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization. Clin Cancer Res 3: 1067-1076.
16. Schmidt H, Taubert H, Meye A, Wurl P, Bache M, et al. (2000) Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease. Cancer Lett 155: 181-190.
17. Mantripragada KK, Diaz de Stahl T, Patridge C, Menzel U, Andersson R, et al. (2009) Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array. Genes Chromosomes Cancer 48: 897-907.
18. Krismann M, Muller KM, Jaworska M, Johnen G, (2002) Molecular cytogenetic differences between histological subtypes of malignant mesotheliomas: DNA cytometry and comparative genomic hybridization of 90 cases. J Pathol 197: 363-371.
19. Wong N, Hui AB, Fan B, Lo KW, Pang E, et al. (2003) Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping. Cancer Genet Cytogenet 140: 124-132.
20. Yen CC, Chen YJ, Lu KH, Hsia JY, Chen JT, et al. (2003) Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction. Int J Oncol 23: 871-881.
21. Yamada S, Kohu K, Ishii T, Ishidoya S, Hiramatsu M, et al. (2004) Gene expression profiling identifies a set of transcripts that are up-regulated inhuman testicular seminoma. DNA Res 11: 335-344.
22. Katoh H, Shibata T, Kokubu A, Ojima H, Loukopoulos P, et al. (2005) Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. J Hepatol 43: 863-874.
23. Salgado R, Gallardo F, Servitje O, Estrach T, Garcia-Muret MP, et al. (2011) Absence of TCR loci chromosomal translocations in cutaneous T-cell lymphomas. Cancer Genet 204: 405-409.
24. Huang YS, Kan MC, Lin CL, Richter JD, (2006) CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA. EMBO J 25: 4865-4876.
25. Igea A, Mendez R, (2010) Meiosis requires a translational positive loop where CPEB1 ensues its replacement by CPEB4. EMBO J 29: 2182-2193.
26. Novoa I, Gallego J, Ferreira PG, Mendez R, (2010) Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control. Nat Cell Biol 12: 447-456.
27. Ortiz-Zapater E, Pineda D, Martinez-Bosch N, Fernandez-Miranda G, Iglesias M, et al. (2012) Key contribution of CPEB4-mediated translational control to cancer progression. Nat Med 18: 83-90.
28. Thorns C, Kuba J, Bernard V, Senft A, Szymczak S, et al. (2012) Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma. Virchows Arch 460: 371-377.
29. Xu L, Liang YN, Luo XQ, Liu XD, Guo HX, (2011) [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi 32: 178-181.
30. Wang C, Su Z, Sanai N, Xue X, Lu L, et al. (2012) microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment. Oncol Rep 27: 1312-1320.
31. Kan MC, Oruganty-Das A, Cooper-Morgan A, Jin G, Swanger SA, et al. (2010) CPEB4 is a cell survival protein retained in the nucleus upon ischemia or endoplasmic reticulum calcium depletion. Mol Cell Biol 30: 5658-5671.
32. Morgan M, Iaconcig A, Muro AF, (2010) CPEB2, CPEB3 and CPEB4 are coordinately regulated by miRNAs recognizing conserved binding sites in paralog positions of their 3'-UTRs. Nucleic Acids Res 38: 7698-7710.